Metabolic and Weight Observations in Four Women Using Triphasic Norgestimate/Ethinylestradiol: A Six-month...

Area of Science:

• Endocrinology
• Pharmacology
• Women's Health

Background:

• Triphasic combined oral contraceptives (COCs) with norgestimate and ethinylestradiol are common.
• Limited data exists on their real-world metabolic effects in routine practice.

Purpose of the Study:

• To describe short-term metabolic and clinical changes in women using a specific triphasic COC.
• To observe effects over six months in a routine clinical setting.

Main Methods:

• Retrospective case series of four women without metabolic disorders.
• Data collected at baseline, 3, and 6 months included glucose, lipids, blood pressure, and weight.
• Descriptive statistics (medians, ranges) were used; no inferential analysis.

Main Results:

• Fasting glucose remained within normal limits.
• Median triglycerides fluctuated, increasing at 3 months then decreasing by 6 months.
• Median total cholesterol and LDL/HDL ratios showed modest increases, while body weight changes were minimal.

Conclusions:

• This small case series offers hypothesis-generating insights into short-term COC use.
• Findings require validation in larger prospective studies.
• Results do not confirm efficacy or generalizability.